Beijing Fund

The Beijing Fund is a fund set up by investors such as Beijing Zhongguancun Science Park Haidian Venture Service Center to introduce advanced Israeli technologies. The wholly-owned subsidiary of Infinity Capital Management Co., Ltd., Infinity (Beijing) Venture Capital Management Co., Ltd. is the fund manager. The fund has invested in a series of quality projects. Among them, IOPtima is a research and development company of non-invasive ophthalmic surgical devices from Israel, which was acquired by Kanghong Pharmaceutical (002773) in March 2018. A series of high-quality projects invested by Beijing Fund will bring high returns to investors of Beijing Fund.